Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 3, 2001, Pages 258-264

  Thomas, P D ^a,b   Forbes, A ^a,b   Nicholls, R J ^a,b   Ciclitira, P J ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

CD25; CD27; CD30; CD69; Pouchitis; Ulcerative colitis

Indexed keywords

CD27 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEITIS; ILEUM MUCOSA; IMMUNOHISTOCHEMISTRY; MEMORY CELL; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0035076418     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750074519     Document Type: Article

References (43)

1. Pouchitis (Workshop)
2. Inflammation in ileal reservoirs: "Pouchitis"
3. Factors influencing bowel function after ileal pouch-anal anastomosis
4. Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis
5. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease
6. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation
7. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease
8. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability
9. Ulcerative colitis: An immunological disease?
10. Regulatory cytokines in inflammatory bowel disease
11. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation
12. CD27: Marker and mediator of T-cell activation?
13. High 1L-4 production is a stable phenotype of CD8negCD45RAnegCD27neg T cells
14. Expression of the activation antigen CD27 in rheumatoid arthritis
15. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis
16. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis
17. Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals
18. Variation in gut-homing CD27- negative lymphocytes in inflammatory colon disease
19. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
20. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. Partial characterisation of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay
21. CD30-mediated signaling promotes the development of human T helper type 2-like T cells
22. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines
23. Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma
24. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells
25. CD30 expression does not discriminate between human Th1- and Th2- type T cells
26. Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels
27. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's garanulomatosis
28. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease
29. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS
30. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)
31. Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis
32. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir
33. Pouchitis after ileal pouch-anal anastomosis: A Pouchitis Disease Activity Index
34. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis
35. Activated CD4+ and CD8+ cells in the colonic mucosa of ulcerative colitis patients: Their relationship to HLA-DR antigen expression on the colonic epithelium and serum soluble CD25 levels
36. Regulation of CD27 expression on subsets of mature T-lymphocytes
37. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis
38. CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors
39. Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells
40. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis
41. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
42. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
43. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis